Clinical Trial Update: High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial of a high-dose vitamin A compound in participants with resectable non-small cell lung cancer was terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Stage Ia Lung Carcinoma Ajcc V7
• Stage Ib Lung Carcinoma
• Stage Iia Lung Carcinoma
• Stage Iiia Lung Carcinoma

Drugs mentioned

• High Dose Vitamin A Compound

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Non Small Cell Lung Cancer, Stage I Lung Cancer | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2024-01-09